Futura Medical Plc logo

Futura Medical Plc(OTC) FAMDF

Market Cap$4.15MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2008)-100%
5 Year-99%
1 Year-93%
1 Month+12%
$0.00
-30.00%
-0.00Today
Futura Medical Plc last closing stock price
MetricPriceDate
Last closeUSD 0.002026-10-01
Futura Medical Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+33.33%USD 0.002026-09-24
1 month+12%USD 0.002026-08-31
3 month-60%USD 0.012026-06-30
Year to date-79.64%USD 0.012025-12-31
1 year-93.17%USD 0.042025-10-01
3 year-99.5%USD 0.562023-10-02
5 year-99.47%USD 0.532021-10-01
Since inception-99.74%USD 1.072008-01-29

Futura Medical Plc Financials at a Glance

Market Cap

$4.15MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£10.25M

Net Income (TTM)

-£9.97M

EPS (TTM)

-$0.01

P/E Ratio

-0.25

Dividend

$0.00

Beta (Volatility)

-0.87 (Low)

Price

$0.00

Volume

1,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.05

Estimated Earnings Date

Apr 14, 2027

FAMDF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Futura Medical Plc

Futura Medical plc is a biotechnology company focused on developing innovative healthcare solutions, particularly in sexual well-being and pain management. The company is known for its flagship product, MED3000, a topical gel designed to treat erectile dysfunction, and has a diverse pipeline of pain relief treatments.

Products and Services
  • MED3000: A topical gel for erectile dysfunction
  • TPR100: A topical diclofenac gel for pain relief
  • CBD100: A topical cannabidiol preparation for discomfort management
Growth Outlook
  • Recent product advancements position the company for market expansion
  • Strong focus on R&D to enhance product offerings and efficacy
  • Potential partnerships could accelerate market penetration and revenue growth
Financial Highlights
  • Q2 2026 revenue of 1,630,211 GBP, a significant increase from previous quarters
  • Gross profit margin improved to 96.5% in Q2 2026
  • Cash and cash equivalents of 1,235,204 GBP as of June 30, 2026
Futura Medical plc operates in a competitive biotechnology sector, with a clear focus on addressing unmet medical needs. The company's flagship product, MED3000, has shown promising results, which could lead to increased market share. The recent financial performance indicates a positive trend, with a notable increase in revenue and an impressive gross profit margin. The company's commitment to research and development is expected to drive future growth, making it an intriguing option for investors interested in the biotechnology field.
AI Generated • Sep 27, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

Alexander James Hanbury Duggan

Website

www.futuramedical.com

Headquarters

Guildford, SU GU2 7YG, GB

FAMDF Financials

Key Financial Metrics (TTM)

Gross Margin

110.59%

Operating Margin

-9.93%

Net Income Margin

-158.21%

Return on Equity

-152.42%

Return on Capital

-319.62%

Return on Assets

-88.30%

Earnings Yield

-4.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.15MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.48B

Volume

1.00K

Avg. Volume

41.91K

Financials (TTM)

Gross Profit

£7.19M

Operating Income

-£9.84M

EBITDA

-£10.00M

Operating Cash Flow

-£4.34M

Capital Expenditure

-£903.74K

Free Cash Flow

-£5.24M

Cash & ST Invst.

£1.24M

Total Debt

£0.00

Futura Medical Plc Performance Analysis

Futura Medical Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31GBP 0N/A
20232023-12-31GBP 3,854,664N/A
20242024-12-31GBP 17,794,970361.6%
20252025-12-31GBP 2,236,012-87.4%
Futura Medical Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-1.1%
Q22025-06-30-85.5%
Q42025-12-31-30.5%
Q22026-06-30134.4%
Futura Medical Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31GBP -0.03-0.4%
20232023-12-31GBP -0.039.2%
20242024-12-31GBP 0.01N/A
20252025-12-31GBP -0.04N/A
Futura Medical Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-75.0%
Q22025-06-30-2812.5%
Q42025-12-3180.2%
Q22026-06-3053.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

£1.63M

-76.7%

Gross Profit

£1.57M

-67.4%

Gross Margin

96.54%

N/A

Market Cap

$4.15MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$296.46K

N/A

Employees

14

N/A

Net Income

-£1.19M

-218.6%

EBITDA

-£1.25M

-241.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

£1.24M

-68.5%

Total Debt

£0.00

N/A

Accounts Receivable

£2.20M

+64.2%

Inventory

£78.43

-44.0%

Long Term Debt

£0.00

N/A

Short Term Debt

£0.00

N/A

Return on Assets

-88.30%

N/A

Return on Invested Capital

-10.23%

N/A

Free Cash Flow

-£2.17M

+44.0%

Operating Cash Flow

-£2.17M

+28.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BVAXFBioVaxys Technology Corp.
$0.13+54.39%
KNBIFKane Biotech Inc.
$0.02+0.00%
ENSCEnsysce Biosciences, Inc.
$0.40-1.20%
PCLOFPharmaCielo Ltd.
$0.04+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NKENike
$33.87-3.64%
NVDANvidia
$233.95+1.34%
SPCXSpace Exploration Technologies
$158.96+7.36%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$29.71-6.46%

Questions About FAMDF

What is the current price of Futura Medical Plc?

Futura Medical Plc is trading at $0.00 per share.

What is the 52-week range for Futura Medical Plc?

Over the past 52 weeks, Futura Medical Plc has traded between $0.00 and $0.05.

How much debt does Futura Medical Plc have?

As of the most recent reporting period, Futura Medical Plc reported total debt of £0.00.

How much cash does Futura Medical Plc have on hand?

Futura Medical Plc reported £4.58M in cash and cash equivalents in its most recent financial results.

What is Futura Medical Plc’s dividend yield?

Futura Medical Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services